Clinical Consequences of IL-1 Genotype on Early Implant Failures in Patients under Periodontal Maintenance
- 1 January 2005
- journal article
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 7 (1), 51-59
- https://doi.org/10.1111/j.1708-8208.2005.tb00047.x
Abstract
Background: Implant failure and biologic complications such as periimplantitis are not completely avoidable. Are there any genetic and microbiologic parameters that Could be used to identify patients at risk for implant failure, preferably prior to treatment? This would result in improvement of the diagnostics, treatment decision, and risk assessment. Purpose: The aims of this retrospective study were to describe (1) the absolute failure rate of Branemark System 0 implants (Nobel Biocare AB, Goteborg, Sweden) consecutively installed over a 10-year period in partially edentulous patients treated for periodontal disease prior to implant treatment and under regular professional maintenance, (2) the rate of interleukin-1 (IL-1) polymorphism in those patients who experienced at least one implant failure during the first year of function, and (3) the prevalence of periodontal pathogens in dental and periimplant sites with and without signs of inflammation. Material and Methods: Of 766 patients, 81 encountered at least one implant failure; 22 patients were clinically examined and were tested genetically for IL-1 genotypes. The presence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella nigrescens was analyzed. Results: The absolute implant survival rate for the whole population was 95.32%; 10.57% of the patients encountered an implant loss. Implant loss in the examined group (n = 22) was 32 of 106 (30.1%); 10 (45%) of the 22 patients were smokers, and 6 (27%) of the 22 patients were IL-1 genotype positive. Patients positive for IL- 1 genotype were not more prone to implant loss; however, a significant synergistic effect with smoking was demonstrated. Between patients who were IL-1 genotype positive and those who were IL-1 genotype negative, the differences in regard to bleeding on probing or periodontal pathogens did not reach statistical significance. Conclusion: The overall implant failure rate in a population treated and maintained for periodontal disease is similar to that of healthy subjects. A synergistic effect found between smoking and a positive IL-1 genotype resulted in a significantly higher implant loss. This indicates that further research with a larger patient group should focus on multifactorial analysis for adequate risk assessmentKeywords
This publication has 41 references indexed in Scilit:
- Long‐term implant prognosis in patients with and without a history of chronic periodontitis: a 10‐year prospective cohort study of the ITI® Dental Implant SystemClinical Oral Implants Research, 2003
- Long‐term evaluation of osseointegrated dental implants in the treatment of partly edentulous patientsJournal of Clinical Periodontology, 2000
- Longitudinal Study of Dental Implants in a Periodontally Compromised PopulationThe Journal of Periodontology, 1999
- Long‐term evaluation of non‐submerged ITI implants. Part 1: 8‐year life table analysis of a prospective multi‐center study with 2359 implants.Clinical Oral Implants Research, 1997
- Periodontal Diseases: PathogenesisAnnals of Periodontology, 1996
- The Successful Use of Osseointegrated Implants for the Treatment of the Recalcitrant Periodontal PatientThe Journal of Periodontology, 1995
- Experimentally induced peri‐implant mucositis. A clinical study in humans.Clinical Oral Implants Research, 1994
- Soft tissue reaction to de novo plaque formation on implants and teeth. An experimental study in the dogClinical Oral Implants Research, 1992
- Osseointegrated Oral ImplantsThe Journal of Periodontology, 1988
- Natural history of periodontal disease in manJournal of Clinical Periodontology, 1986